{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:40:44Z","timestamp":1791567644355,"version":"4.3.4"},"reference-count":119,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304593"],"award-info":[{"award-number":["82304593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Pulmonary fibrosis (PF) is a progressive and fatal interstitial lung disease characterized by excessive extracellular matrix deposition and fibroblast activation. Current antifibrotic therapies, such as nintedanib and pirfenidone, slow disease progression but fail to halt fibrosis or significantly improve survival. Macrolides, a class of antibiotics with immunomodulatory and anti-inflammatory properties, have emerged as potential adjunctive therapies for PF. Preclinical studies demonstrate that macrolides attenuate fibrogenesis through multifaceted mechanisms: suppression of TGF-\u03b2\/Smad and JNK\/c-Jun signaling, inhibition of pro-fibrotic cytokine release, modulation of macrophage polarization toward antifibrotic M2 phenotypes, and induction of apoptosis in senescent cells. Clinically, macrolides have shown promise in reducing acute exacerbations in idiopathic pulmonary fibrosis (IPF), mitigating radiation pneumonitis, and attenuating post-infectious fibrotic changes. However, conflicting results from clinical trials and the absence of large-scale randomized studies highlight the need for further validation. This review evaluates the antifibrotic mechanisms and therapeutic potential of macrolides in PF, integrating preclinical and clinical evidence. We aim to inform future research directions by elucidating their role in modulating key pathways and addressing unresolved efficacy questions.<\/jats:p>","DOI":"10.1177\/17534666251346108","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:22:35Z","timestamp":1750818155000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8880-4309","authenticated-orcid":false,"given":"Qingqing","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory of Ethnopharmacology, Tissue-orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2412-3901","authenticated-orcid":false,"given":"Xiang","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2005230"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018"},{"key":"e_1_3_4_4_2","article-title":"Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis","volume":"377","author":"Liu GY","year":"2022","unstructured":"Liu GY, Budinger GRS, Dematte JE. Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. BMJ 2022; 377: e066354.","journal-title":"BMJ"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2018"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30355-6"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705751"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0360UP"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1647040"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01052-2"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0322-7"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61144-1"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4956"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201409-1626ED"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600112"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/692352"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.03979.x"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1076"},{"key":"e_1_3_4_20_2","first-page":"346","article-title":"Macrolide immunosuppressants","volume":"9","author":"Mrowietz U.","year":"1999","unstructured":"Mrowietz U. Macrolide immunosuppressants. Eur J Dermatol EJD 1999; 9: 346\u2013351.","journal-title":"Eur J Dermatol EJD"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/01902148.2010.492895"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00720-2022"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00628-2018"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00078-09"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/all.14768"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00302"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02064"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn007"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3457-3461.2004"},{"key":"e_1_3_4_30_2","first-page":"4009","article-title":"Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme","volume":"175","author":"Shao MXG","year":"2005","unstructured":"Shao MXG, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol Baltim Md 1950 2005; 175: 4009\u20134016.","journal-title":"J Immunol Baltim Md 1950"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-6618(94)80009-X"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00607-07"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1930-1933.2001"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12960"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003134"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2163"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2008.01.010"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.121.000300"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03778-8"},{"key":"e_1_3_4_40_2","first-page":"254","article-title":"Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"86","author":"Yao G-Y","year":"2013","unstructured":"Yao G-Y, Ma Y-L, Zhang M-Q, et al. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis. Respir Int Rev Thorac Dis 2013; 86: 254\u2013260.","journal-title":"Respir Int Rev Thorac Dis"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70107-9"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174191"},{"key":"e_1_3_4_43_2","article-title":"Macrolide antibiotics (including azithromycin) for cystic fibrosis","volume":"2","author":"Southern KW","year":"2024","unstructured":"Southern KW, Solis-Moya A, Kurz D, et al. Macrolide antibiotics (including azithromycin) for cystic fibrosis. Cochrane Database Syst Rev 2024; 2: CD002203.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.1997.tb00071.x"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00618-3"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709819"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168946"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2018.07.008"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/01902140802093238"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-16"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0093-2021"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-52"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.04.015"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112426"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-016-0117-2"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0174OC"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/137.3.564"},{"key":"e_1_3_4_58_2","article-title":"Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: Inhibition by macrolides","volume":"272","author":"Tamaoki J","year":"1997","unstructured":"Tamaoki J, Takeyama K, Yamawaki I, et al. Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: Inhibition by macrolides. Am J Physiol 1997; 272: L15-19.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00021246"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155049"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.5.7735618"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.6.2137"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.3.186"},{"key":"e_1_3_4_64_2","first-page":"2909","article-title":"Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages","volume":"163","author":"Tamaoki J","year":"1999","unstructured":"Tamaoki J, Kondo M, Kohri K, et al. Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. J Immunol Baltim Md 1950 1999; 163: 2909\u20132915.","journal-title":"J Immunol Baltim Md 1950"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9703098"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.08.058"},{"key":"e_1_3_4_67_2","first-page":"5211","article-title":"Azithromycin attenuates acute radiation-induced lung injury in mice","volume":"14","author":"Tang F","year":"2017","unstructured":"Tang F, Li R, Xue J, et al. Azithromycin attenuates acute radiation-induced lung injury in mice. Oncol Lett 2017; 14: 5211\u20135220.","journal-title":"Oncol Lett"},{"key":"e_1_3_4_68_2","first-page":"52","article-title":"Azithromycin mitigates cisplatin-induced lung oxidative stress, inflammation and necroptosis by upregulating SIRT1, PPAR\u03b3, and Nrf2\/HO-1 signaling","volume":"16","author":"Hassanein EHM","year":"2022","unstructured":"Hassanein EHM, Sayed GA, Alzoghaibi AM, et al. Azithromycin mitigates cisplatin-induced lung oxidative stress, inflammation and necroptosis by upregulating SIRT1, PPAR\u03b3, and Nrf2\/HO-1 signaling. Pharm Basel Switz 2022; 16: 52.","journal-title":"Pharm Basel Switz"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-3056"},{"key":"e_1_3_4_70_2","article-title":"Clarithromycin attenuates radiation-induced lung injury in mice","volume":"10","author":"Lee SJ","year":"2015","unstructured":"Lee SJ, Yi C, Heo RW, et al. Clarithromycin attenuates radiation-induced lung injury in mice. PloS One 2015; 10: e0131671.","journal-title":"PloS One"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.5.609"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753466619890538"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101679"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-1275-8"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1328348"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512412"},{"key":"e_1_3_4_77_2","first-page":"2820","article-title":"Deglycosylated azithromycin attenuates bleomycin-induced pulmonary fibrosis via the TGF-\u03b21 signaling pathway","volume":"26","author":"Ruan H","year":"2021","unstructured":"Ruan H, Gao S, Li S, et al. Deglycosylated azithromycin attenuates bleomycin-induced pulmonary fibrosis via the TGF-\u03b21 signaling pathway. Mol Basel Switz 2021; 26: 2820.","journal-title":"Mol Basel Switz"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0289OC"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2018-0267ED"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.343129.120"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101633"},{"key":"e_1_3_4_82_2","first-page":"8293","article-title":"Local delivery of azithromycin nanoformulation attenuated acute lung injury in mice","volume":"27","author":"Alrashedi MG","year":"2022","unstructured":"Alrashedi MG, Ali AS, Ahmed OA, et al. Local delivery of azithromycin nanoformulation attenuated acute lung injury in mice. Mol Basel Switz 2022; 27: 8293.","journal-title":"Mol Basel Switz"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117548"},{"key":"e_1_3_4_84_2","first-page":"67","article-title":"Immunomodulatory effects of macrolide antibiotics \u2013 part 1: biological mechanisms","volume":"81","author":"Altenburg J","year":"2011","unstructured":"Altenburg J, de Graaff CS, van der Werf TS, et al. Immunomodulatory effects of macrolide antibiotics \u2013 part 1: biological mechanisms. Respir Int Rev Thorac Dis 2011; 81: 67\u201374.","journal-title":"Respir Int Rev Thorac Dis"},{"key":"e_1_3_4_85_2","first-page":"392","article-title":"Intervention by azithromycin on bleomycin-induced lung injury in rats and its mechanisms","volume":"25","author":"Ma J","unstructured":"Ma J, He B, Li N, et al. Intervention by azithromycin on bleomycin-induced lung injury in rats and its mechanisms. Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis; 25: 392\u2013395.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200212-1437OC"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0327OC"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115147"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202200106"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0082-2017"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1408OC"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702008000600016"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0541OC"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0511-3"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1650OC"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152690"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01011-06"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1489198"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00235-13"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0138OC"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00037005"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12077"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00534-2020"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70105-X"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00067-9"},{"key":"e_1_3_4_107_2","first-page":"242","article-title":"Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis","volume":"33","author":"Kuse N","year":"2016","unstructured":"Kuse N, Abe S, Hayashi H, et al. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis. Sarcoidosis Vasc Diffuse Lung Dis 2016; 33: 242\u2013246.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"e_1_3_4_108_2","first-page":"478","article-title":"Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls","volume":"87","author":"Kawamura K","year":"2014","unstructured":"Kawamura K, Ichikado K, Suga M, et al. Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls. Respir Int Rev Thorac Dis 2014; 87: 478\u2013484.","journal-title":"Respir Int Rev Thorac Dis"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-017-0437-z"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0253-x"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0779-9"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0071-2018"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202103-266OC"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2786"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9304-21"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1159\/000341982"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.12.22"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.17111"},{"key":"e_1_3_4_120_2","unstructured":"Saha A Vaidya PJ Chavhan VB et al. Combined pirfenidone azithromycin and prednisolone in post- H1N1 ARDS pulmonary fibrosis."}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251346108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17534666251346108","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251346108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:20:04Z","timestamp":1767687604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17534666251346108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":119,"alternative-id":["10.1177\/17534666251346108"],"URL":"https:\/\/doi.org\/10.1177\/17534666251346108","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/17534666251346108\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251346108\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"17534666251346108"}}